

| 카탈로그 번호 | HW412026 |
|---|---|
| 종 반응성 | Human |
| 응용 분야 | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| 숙주 종 | Human |
| 클론성 | Monoclonal |
| 이소타입 | IgG |
| 클론 ID | HGS101 |
| 생물학적 활성 | HGS101 (1 h) shows EC 50 values of 0.001 ug/mL for Maraviroc ()-sensitive, 0.0003 ug/mL for Maraviroc -resistant, and 0.00002 ug/mL for Maraviroc -resistant HIV-1 in the presence of Maraviroc in JC6 cells [1]. HGS101 (1 h) shows EC 50 values of 0.03 ug/mL for Maraviroc -sensitive, 0.03 ug/mL for Maraviroc -resresistant, and 0.01 ug/mL for Maraviroc -resistant HIV-1 in the presence of Maraviroc in PBMCs [1]. HGS101 (0.3 ug/ mL, 1 h) restores Maraviroc inhibition (EC 50 of 0.007 nM) of Maraviroc -resistant HIV-1 in PBMCs [1]. HGS101 (10 mg/kg, i.v., every 15 days for 10 times) shows anti-HIV activity by inhibiting CCR5 signaling in simian immunodeficiency virus-uninfected RMs models [2]. . Reduced the levels of CCR5 + T-cells in blood and lymph nodes. Induced a complex anatomic redistribution of CD25 + T-cell. Induced specific changes in the transcriptional profile of leukocytes. |
| 발현 시스템 | Mammalian cells |
| 타겟 | C-C CKR-5, CC-CKR-5, CMKBR5, HIV-1 fusion coreceptor, CHEMR13, CCR5, C-C chemokine receptor type 5, CD195, CCR-5 |
| 내독소 수준 | < 10 EU/mg |
| 순도 | >95% purity as determined by SDS-PAGE. |
| 정제 | Protein A/G purified from cell culture supernatant. |
| 등록번호 | P51681 |
| 형태 | Liquid |
| 저장 완충액 | 0.01M PBS pH 7.4 데이터시트 인쇄본 또는 로트별 COA에 기재된 구체적인 완충액 정보를 참조하세요. |
| 안정성 및 저장 | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| 대체 이름 | HGS101 |
| 배경 | C-C chemokine receptor type 5 (CD195/CCR5) is a ~40 kDa protein. Receptor for a number of inflammatory CC-chemokines including CCL3/MIP-1-alpha, CCL4/MIP-1-beta and RANTES and subsequently transduces a signal by increasing the intracellular calcium ion level. May play a role in the control of granulocytic lineage proliferation or differentiation. Participates in T-lymphocyte migration to the infection site by acting as a chemotactic receptor. 1. Sharapova, TN. et al. (2018) Acta naturae 10, 115-120. PMID: 30713770 |
| 참고 문헌 | 1. Latinovic O, et al. CCR5 antibodies HGS004 and HGS101 preferentially inhibit drug-bound CCR5 infection and restore drug sensitivity of Maraviroc-resistant HIV-1 in primary cells. Virology. 2011 Mar 1;411(1):32-40. [HW412026] 2. aaffe JE, et al. CCR5 blockade is well tolerated and induces changes in the tissue distribution of CCR5+ and CD25+ T cells in healthy, SIV-uninfected rhesus macaques. J Med Primatol. 2012 Feb;41(1):24-42. [HW412026] |
| 참고사항 | For research use only. Not suitable for clinical or therapeutic use. |

SDS-PAGE for Research Grade Anti-Human CD195/CCR5 (HGS101)


+86-027-65523339
중국 우한시 심둔사로 666번지 C동, 우한, 430206

中文
English
한국어
日本語
Español
Français
Русский